Moore Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-745,100
Closed -$199K – 333
2016
Q3
$199K Hold
745,100
– – 0.01% 243
2016
Q2
$179K Hold
745,100
– – 0.01% 258
2016
Q1
$85K Hold
745,100
– – ﹤0.01% 228
2015
Q4
$84K Hold
745,100
– – ﹤0.01% 276
2015
Q3
$142K Sell
745,100
-245,100
-25% -$83.4K 0.01% 268
2015
Q2
$693K Buy
+990,200
New +$685K 0.01% 385

Other funds holding GCVRZ

Moore Capital Management's GCVRZ Position: Q4 2016 in Review

Moore Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 745,100 shares — an estimated $199K sold.

Moore Capital Management first reported a position in GCVRZ in Q2 2015 and held it in 6 quarters. The position peaked at $693K in Q2 2015. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

  • Moore Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
  • Moore Capital Management sold 745,100 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $199K.
  • Moore Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 6 quarters.
  • Moore Capital Management's Sanofi Contingent Value Rights position peaked at $693K in Q2 2015.
  • 120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Moore Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.